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INRAbstract Automated Implantable Cardioverter Deﬁbrillators (AICD), simply known as an
Implantable Cardioverter Deﬁbrillator (ICD), has been used in patients for more than 30 years.
An Implantable Cardioverter Deﬁbrillator (ICD) is a small battery-powered electrical impulse gen-
erator that is implanted in patients who are at a risk of sudden cardiac death due to ventricular ﬁb-
rillation, ventricular tachycardia or any such related event. Typically, patients with these types of
occurrences are on anticoagulant therapy. The desired International Normalized Ratio (INR) for
these patients is in the range of 2–3 to prevent any subsequent cardiac event. These patients possess
a challenge to the dentist in many ways, especially during oral surgical procedures, and these chal-
lenges include risk of sudden death, control of post-operative bleeding and pain.
This article presents the dental management of a 60 year-old person with an ICD and concomi-
tant anticoagulant therapy. The patient was on multiple medications and was treated for a grossly
neglected mouth with multiple carious root stumps. This case report outlines the important issues in
managing patients ﬁtted with an ICD device and at a risk of sudden cardiac death.
ª 2015 TheAuthors. Production and hosting by Elsevier B.V. on behalf of King SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Automated Implantable Cardioverter Deﬁbrillators (AICDs)
or otherwise simply known as Implantable Cardioverter
Deﬁbrillators (ICDs) have been in use for more than 30 years.
An ICD is a small battery-powered electrical impulse genera-
tor that is implanted in patients who are at a risk of sudden
cardiac death due to ventricular ﬁbrillation and ventricular
166 A.H. Shah et al.tachycardia (Roedig et al., 2010). ICDs are widely used in
patients with malignant ventricular tachyarrhythmias and pre-
vention of sudden cardiac death (Washizuka et al., 2005). ICD
devices are also utilized to treat Brugada syndrome, and the
devices were found to provide full protection against sudden
death related to primary ventricular ﬁbrillation (Cappato
et al., 2012). Pacemaker or ICD implantation among patients
receiving anticoagulant therapies is a common occurrence
(Bernard et al., 2012). The device is programed to detect car-
diac arrhythmia and correct the condition by delivering a jolt
of electricity (Theodotou et al., 2009). ICD deﬁnitively reduces
the incidence of sudden cardiac death in younger patients on
optimal medical therapy; however, whether the elderly popula-
tion derives similar beneﬁts remains unknown (Revenco et al.,
2011). Maintaining anticoagulation increases the risk of bleed-
ing complications for most operative procedures, whereas dis-
continuing anticoagulant therapy over a period of time may
increase the risk of thromboembolic complications (Bernard
et al., 2012). Patients with cardiovascular disease constitute
risk cases in dental practice, particularly in the absence of ade-
quate medical controls (Steinhauer et al., 2005); therefore, den-
tists must understand the medical problems of each individual
patient, the treatments received, and the potential dental treat-
ments. The aim of presenting this case report is to outline the
important issues when dealing with patients who present the
risk of sudden cardiac death, who are ﬁtted with an ICD device
and who receive warfarin therapy.
2. Case report
A 60 year-old Saudi male patient was referred from the
Interns’ clinic, College of Dentistry, King Saud University.
The patient reported to the Special Care Dentistry clinic within
the Maxillofacial Surgery Department in the College of
Dentistry, King Saud University with a grossly neglected
mouth. The patient had many decayed and missing teeth
(Fig. 1) and was unable to obtain proper dental consulta-
tion and treatment due to his complex medical history.
Recently, he experienced pain and tenderness in the lower right
posterior area of his mouth. The patient is married, living with
his family and a non-smoker. He had previously undergone a
few dental procedures in the past such as extractions, and he
brushes occasionally with a ﬂuoridated tooth paste.Figure 1 Oral health status of the patient at the initial visit.The patient was on treatment and follow up for multiple
medical conditions, including anterior wall myocardial infarc-
tion and a left ventricular (LV) apical clot with peripheral vas-
cular lower limb embolism 10 years ago. The patient was
hospitalized in July 2010 with a signiﬁcant coronary artery dis-
ease and left ventricular dysfunction (LV failure), which was
due to a large organized LV apical clot that caused shortness
of breath. After cardiac catheterization, the patient was diag-
nosed with Ischemic Heart Disease (IHD), Acute Left
Ventricular Failure (LVF) and New York Heart Association
Class III (NYHA III) Heart Failure. Subsequently, the inser-
tion of a subcutaneous Implantable Cardioverter
Deﬁbrillator (ICD) was necessitated. Although the patient
was stable, he was categorized with NYHA III heart failure
with a high risk of cardiac sudden death 5 months prior to
his ﬁrst dental visit to our department.
The patient is being followed up at the King Fahad Cardiac
Centre, King Khalid University Hospital (KKUH), King Saud
University, Riyadh. The patient is taking warfarin, and the
desired therapeutic range for his International Normalized
Ratio (INR) is 2–3. Blood investigations including INR and
adjustment of warfarin dosage are performed every 2–3 weeks.
The patient presented with laboratory investigation reports
from the warfarin clinics at KKUH 1 week prior to his ﬁrst
dental appointment. The patient had been taking warfarin
4 mg once daily for the last few weeks; however, his dosage
had been increased to 4.5 mg to achieve the target INR.
Other than warfarin, the patient was on 20 mg Simvastatin,
6.25 mg Carvedilol and 81 mg Aspirin once daily.
A treatment plan was formulated for the patient during an
initial consultation with his physician regarding the effect of
dental treatment on his general health. A referral to anticoag-
ulation clinics for INR regularization was arranged. The
patient was given assurance, education and motivation for oral
hygiene. Extraction of the lower right third molar and the
remaining roots with the potential risks was explained to the
patient. Subsequently, restoration of the upper right central
incisor as well as realistic treatment options for prosthetic
rehabilitation of missing teeth were discussed with the patient.
2.1. Summary at the initial visit
A Dental Panaromic Tomograph (DPT) (Fig. 2) and periapi-
cal radiographs of the lower right third molar and the upper
right central incisor were taken. On the spot INR was per-
formed using the CoaguChek apparatus, and the readingFigure 2 OPG revealing the dental status and bone.
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molar revealed irreversible pulpitis.
The patient was reassured of his situation and oral hygiene
instructions were provided. The treatment plan was discussed
with the patient, including possible alternatives and problems
that may arise during the course of treatment. Consulting
the anticoagulation clinics at KKUH for regulation of INR
was recommended to the patient because the INR level (INR
4.2) was higher than the target level (INR 2–3) as well as
higher than the level considered safe (INR 4) for any dental
intervention (Perry et al., 2007). Furthermore, the patient
was told that he would need a thorough maintenance of his
oral hygiene due to the impact of any dental intervention on
his underlying medical condition. The patient was instructed
to bring the complete medical report during his next visit
and was given a referral letter to be discussed with his physi-
cian at KKUH. The patient was advised to take a
Paracetamol tablet for pain because Ibuprofen, which is a
non-steroidal anti-inﬂammatory drug (NSAID), could lead
to a possible interaction with warfarin (Hakonsen et al., 2009).
2.2. Subsequent visits
After revisiting the anticoagulation clinics at KKUH, the war-
farin dosage for the patient was reverted to 4 mg for 1 week.
The patient brought a letter from the medical specialist
describing his condition and advising care to be taken during
the dental treatment. No absolute contraindication was indi-
cated for the proposed dental treatment. The patient did not
require antibiotic prophylaxis for his cardiac condition as
per the National Institute for Health and Clinical Excellence
(NICHE) guidelines March-2008 (Stokes et al., 2008). Caries
excavation was performed for the upper right central incisor,
and temporary restoration was placed with a Dycal (calcium
hydroxide cement) base. All procedures were performed using
a stress reduction protocol and the patient was monitored
throughout the treatment.
2.3. Follow up visits
Permanent restoration was performed on the upper central
incisor using a glass ionomer cement base and was restored
with composite. All root stumps were extracted sequentially
with care. INR was conducted at each visit using the
CoaguChek device. In total, 9 teeth were extracted in fourFigure 3 On Spot INR testing with CoaguChek apparatus.visits. At ﬁrst, the mobile remaining root stumps of tooth num-
bers 18 and 16 involving the upper right posterior quadrant
were extracted. At this visit, the INR checked with
CoaguChek was 2.07. All regional blocks were avoided, and
a combination of Prilocaine + felypressine (Citanest 3%-
Octapressin) was used as a local anesthetic of choice.
Surgicel was used as a hemostatic agent for post-operative
bleeding control and the wounds were sutured using Vicryl
3-0 absorbable sutures.
The patient was given verbal as well as written post-opera-
tive instructions for the use of a 4.8 % Tranexamic acid
mouthwash (10 ml for 2 min in the mouth, 4–5 times a day
for 3–5 days). In case of any complication or excessive post-
operative bleeding, the patient was advised to attend the clinic
or contact an oral surgeon on call by phone. Instructions for
post-operative eating and mouth cleaning were given and the
patient was asked to follow up after 1 week. Remaining root
stumps of other quadrants were extracted according to the
order of their mobility. During the next three visits (each a
week apart), tooth numbers 13, 12, 21, 23, 24, 36 and 48 were
extracted. First, the teeth in the right upper anterior quadrant
were extracted then the left upper and lower quadrant teeth
were extracted at the same time and lastly, tooth number 48
in the lower right posterior quadrant was extracted. Each
appointment was kept as short as possible to not stress the
patient. None of these appointments lasted more than 45 min
including the post-operative measures and instructions. The
patient’s INR was recorded at each visit with CoaguChek
(Fig. 3), and the INR was found to be 2.04, 2.6 and 2.4, respec-
tively. During extractions, the patient was continuously moni-
tored with the help of a pulse oximeter. Topical anesthesia and
local inﬁltration anesthesia (Prilocaine + felypressine
(Citanest 3%-Octapressin) were used except for the lower right
third molar on the last visit in which a careful Infra alveolar
nerve block was used with a technique that minimizes chances
of an intravascular injection (Khalil, 2014). A similar post-op-
erative care was delivered as during previous visits, and
Surgicel packs were used as hemostatic agents. The same
post-operative instructions were given, including the use of
Tranexamic acid mouth wash. The patient returned at each
visit with an uneventful report, except for a minor oozing of
blood. Moreover, the patient-reported post-operative pain
was rated on a scale of 10, and the patient was recalled after
3 weeks.2.4. Recall visit
The patient returned on the scheduled appointment, and his
post-operative healing was uneventful with minimal post-op-
erative pain and bleeding. The reported pain after the last
extraction was more than the previous extractions; however,
the tissue healing was progressing as expected. The patient
desired to have an implant or undergo ﬁxed prosthodontic
rehabilitation for the lost teeth; however, these options were
not feasible due to his medical condition. The patient agreed
to receive a removable partial denture in both arches, and
impressions were made of both the upper and lower jaws.
Using a bite registration and re-conﬁrmatory approach, the
upper and lower partial dentures were fabricated. The patient
was ultimately satisﬁed with the achieved occlusion and
esthetics (Fig. 4).
Figure 4 Patient satisﬁed with the ﬁnal result and esthetics.
Figure 5 Careful tissue manipulation during oral surgery for the
patient.
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3.1. Stress reduction protocol
Dentists are required to obtain a detailed medical history of
patients with ICD. The presence of any signs of cardiac
arrhythmia should be carefully evaluated and the patient’s
physician should always be consulted. Stress reduction proto-
cols should be implemented in all patients to reduce the risk of
cardiovascular effects caused by stress during dental treatment.
Stress reduction protocols involve the establishment of a good
rapport with the patient, suitable appointment times and dura-
tion, successful local anesthesia and sedation if necessary
(Steinhauer et al., 2005). The dental session should be kept
as short as possible and should be terminated if the patient
develops any signs or symptoms of being tired or cannot toler-
ate the procedure (Wraith, 1999). The patient was monitored
with a pulse oximeter during the dental procedure to detect
any changes in heart beat rate and oxygen saturation; however,
no sedation was deemed necessary for the patient. Any com-
plex dental procedure must be explained very clearly to the
patients and can be discussed at several appointments to
reduce patient stress.
3.2. The use and selection of local anesthetic
The stimulation of excessive amounts of adrenaline from the
body and the use of external adrenaline in the local anesthetic
solution may produce life threatening arrhythmias in several
patients (Campbell et al., 1996). The use of local anesthetics
in patients with ICD should be carefully evaluated. Local anes-
thetics should be used with caution, dose should be minimized
and patients should be continuously monitored. In addition,
excessive amounts of vasoconstrictor should be avoided. The
most commonly used vasoconstrictor with lidocaine as the
local anesthetic is adrenaline. Adrenaline can induce multiple
changes in the cardiovascular dynamic system (Malamed,
2012). With our patient, to avoid any complications related
to adrenaline, the combination of prilocaine and felypressine
(Citanest 3%-Octapressin) was used as the local anesthetic.
Effective pain control during and after dental treatment is
important in such patients because the dental treatment may
trigger cardiovascular changes and risk the development of
arrhythmias (Jowett and Cabot, 2000). Aspiration is importantduring the local anesthetic injection to avoid intravascular
injections, which are associated with many systemic complica-
tions (Malamed, 2012). If the dentist needs to use a nerve
block, many techniques have been described in the literature
as modiﬁcations of the conventional inferior alveolar nerve
block to minimize the risk of intravascular injections (Khalil,
2014), such as injection at the retromolar area and the pterygo-
mandibular space (Okamoto et al., 2000; Suazo Galdames
et al., 2008). Moreover, all regional blocks were avoided in this
case except the infra alveolar nerve block for the lower right
third molar, which was ﬁrm and needed more adequate anes-
thetic control. Local inﬁltration was preferred to avoid chances
of bleeding into the tissue spaces, particularly the lingual
spaces. During oral surgical procedure preparation, the inci-
sion and tissue manipulation were reported to cause maximum
changes in the heart rate and ECG waves (Miller et al., 1998).
Care was exercised during the extraction of the root stumps to
avoid any bone cutting and excessive tissue manipulation dur-
ing the procedure (Fig. 5).
3.3. Dental and surgical devices
Patients with ﬁtted cardiac devices that control heart function
are at a risk of any electrical devices used in dentistry. Several
dental devices such as electrosurgery and ultrasonic scalers
may interfere with the implanted deﬁbrillator (Roedig et al.,
2010), and several devices such as an electrical pulp tester,
amalgamator, electric tooth brush, and curing light may not
cause any interference with implantable devices such as the
pacemaker (Miller et al., 1998). No signiﬁcant event was
observed when using the curing light for restoration of the
anterior upper tooth.
3.4. Effect of warfarin
Many patients with ICD undergo anticoagulant therapy for
their original event. Warfarin, which is the most commonly
used oral anticoagulant drug, is a vitamin K antagonist that
is rapidly absorbed one hour after ingestion and possess a
half-life of 36 h. Extraction and several other dental proce-
dures should be performed after evaluation of the patient’s
International Normalized Ratio (INR) (Richards, 2008). The
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eral other conditions 3.0–4.0 is advised, like for patients with
mechanical heart valves or recurrent episodes of emboli
(Ishibashi et al., 1996). A theoretical risk of post-operative
bleeding appears to be minimal because hemorrhages can be
controlled by local hemostatic measures, avoiding thromboem-
bolism, which may occur after anticoagulant therapy with-
drawal (Kudsi et al., 2012). In our case, the INR therapeutic
range was between 2 and 3. Dental surgical procedures can
be safely performed up to INR levels of 4 (Barrett, 2004;
Balevi, 2010; Perry et al., 2007). However, the patient reported
an INR of 4.2 during the initial visit, thus needing readjust-
ment of warfarin therapy. Furthermore, INR should be con-
ﬁrmed on the day of procedure (Karsli et al., 2011). With
the help of CoaguChek, the patient’s INR was monitored on
the spot (Fig. 3). Local measures after dental surgical proce-
dures are valuable to control bleeding. In our patient, bleeding
control was achieved with local hemostatic agents (Surgicel),
resorbable suturing and tranexamic acid mouth wash.
Moreover, NSAID analgesics such as Ibuprofen was avoided
for post-operative pain control; instead, a combination of
Paracetamol and Codeine Phosphate tablets was prescribed.
3.5. Antibiotic prophylaxis
Prophylactic antibiotics are not recommended to be used in
patients with ICDs before dental treatment according to the
American Heart Association guidelines and the National
Institute for Health and Clinical Excellence UK (NICE guide-
lines UK 2008) (Baddour et al., 2010, 2011). The risk of devel-
oping device-related infection in patients with ICD is
considered low; therefore, antibiotic prophylaxis is not needed
for these types of patients (Baddour et al., 2010). The patient
was not advised to receive any antibiotic prophylaxis during
the course of the treatment.
3.6. Prosthetic management options
The prosthodontic rehabilitation of patients with ICD has
always been a challenge to prosthodontists and general practi-
tioners because of uncontrolled post-operative bleeding.
Recently, the dental implant placement has been a preferred
choice as the prosthetic replacement because patients primarily
prefer ﬁxed prostheses compared with removable prostheses
(Diz et al., 2013). The risk of implant surgery has restricted
the treatment option for ICD patients, and high mortality
rates have been shown in ICD patients compared with normal
cardiac patients (Zareba et al., 2003). Fluctuating INR has
also been of concern regarding dental surgical procedures
(Tompkins et al., 2010). The risk of post-operative bleeding
and the mortality rate of patients during surgical dental proce-
dures have been documented (Steinhauer et al., 2005). Oral
anti-coagulant treatment such as warfarin and prophylactic
doses of aspirin in patients with ICD may need regular moni-
toring and change in doses, which may affect post-operative
bleeding (Al-Khadra, 2003). In the above discussed case, the
patient preferred the ﬁxed prostheses; however, the ﬂuctuating
INR, physician concern, patient’s oral hygiene and periodon-
tal condition only allowed the removable prostheses options.
For example, dental implants were questionable because the
OPG revealed progressive bone loss (Fig. 2), and the patientwas satisﬁed with the rehabilitation results (Fig. 3). Further
follow up visits are scheduled for this patient.
Such medically compromised patients experience a lot of
inconveniences until they receive proper care, which can pro-
vide the patients with better oral health status. Although the
systemic disease or condition can be intimidating, a detailed
history, proper consultation and careful monitoring can make
the case clear and manageable.
Conﬂict of interests
The authors declare no conﬂict of interests.
Ethical approval and patient’s consent
After obtaining an informed consent from the patient, ethical
approval was granted from College of Dentistry Research
Council (CDRC), College of Dentistry, King Saud University.
Acknowledgment
The authors would like to thank the Ex Director of Clinics,
Dr. Sulieman AlJohany for procurement of the CoaguChek
apparatus at the College of Dentistry, King Saud University.
References
Al-Khadra, A.S., 2003. Implantation of pacemakers and implantable
cardioverter deﬁbrillators in orally anticoagulated patients. Pacing
Clin. Electrophysiol. 26 (1 Pt 2), 511–514.
Baddour, L.M., Epstein, A.E., Erickson, C.C., Knight, B.P., Levison,
M.E., Lockhart, P.B., et al, 2010. Update on cardiovascular
implantable electronic device infections and their management: a
scientiﬁc statement from the American Heart Association.
Circulation 121 (3), 458–477.
Baddour, L.M., Epstein, A.E., Erickson, C.C., Knight, B.P., Levison,
M.E., Lockhart, P.B., et al, 2011. A summary of the update on
cardiovascular implantable electronic device infections and their
management: a scientiﬁc statement from the American Heart
Association. J. Am. Dent. Assoc. 142 (2), 159–165.
Balevi, B., 2010. A decision-tree analysis. Oral Surg. Oral Med. Oral
Pathol. Oral Radiol. Endod. 110, 691–697.
Barrett, D., 2004. Management of dental patients on warfarin therapy
in a primary care setting. Dent. Update 31 (10), 618.
Bernard, M.L., Shotwell, M., Nietert, P.J., Gold, M.R., 2012. Meta-
analysis of bleeding complications associated with cardiac rhythm
device implantation. Circ. Arrhythm. Electrophysiol. 5 (3), 468–474.
Campbell, J.H., Huizinga, P.J., Das, S.K., Rodriguez, J.P., Gobetti,
J.P., 1996. Incidence and signiﬁcance of cardiac arrhythmia in
geriatric oral surgery patients. Oral Surg. Oral Med. Oral Pathol.
Oral Radiol. Endod. 82 (1), 42–46.
Cappato, R., Smith, W.M., Hood, M.A., Crozier, I.G., Jordaens, L.,
Spitzer, S.G., et al, 2012. Subcutaneous chronic implantable
deﬁbrillation systems in humans. J. Interv. Card. Electrophysiol.
34 (3), 325–332.
Diz, P., Scully, C., Sanz, M., 2013. Dental implants in the medically
compromised patient. J. Dent. 41 (3), 195–206.
Hakonsen, G.D., Pettersen, M.H., Skurtveit, S., Giverhaug, T., 2009.
Concomitant use of warfarin, analgesics and anti-inﬂammatory
agents. Tidsskr. Nor. Laegeforen. 129 (12), 1217–1220.
Ishibashi, Y., Aoki, H., Ohba, J., Kamikubo, Y., Morimoto, K.,
Kumasaka, A., 1996. PT-INR as a parameter for anticoagulant
therapy after valve replacement surgery. Kyobu Geka 49 (11), 906–
908.
170 A.H. Shah et al.Jowett, N.I., Cabot, L.B., 2000. Patients with cardiac disease:
considerations for the dental practitioner. Br. Dent. J. 189 (6),
297–302.
Karsli, E.D., Erdogan, O., Esen, E., Acarturk, E., 2011. Comparison
of the effects of warfarin and heparin on bleeding caused by dental
extraction: a clinical study. J. Oral Maxillofac. Surg. 69 (10), 2500–
2507.
Khalil, H., 2014. A basic review on the inferior alveolar nerve block
techniques. Anesth. Essays Res. 8 (1), 3–8.
Kudsi, Z., Dalati, M.H., Sibai, L., Koussayer, L.T., 2012.
Management of bleeding disorders in the dental practice: managing
patients on anticoagulants. Dent. Update 39 (5), 358–360, 363.
Malamed, S., 2012. Handbook of Local Anesthesia, sixth ed. Mosby.
Miller, C.S., Leonelli, F.M., Latham, E., 1998. Selective interference
with pacemaker activity by electrical dental devices. Oral Surg. Oral
Med. Oral Pathol. Oral Radiol. Endod. 85 (1), 33–36.
Okamoto, Y., Takasugi, Y., Moriya, K., Furuya, H., 2000. Inferior
alveolar nerve block by injection into the pterygomandibular space
anterior to the mandibular foramen: radiographic study of local
anesthetic spread in the pterygomandibular space. Anesth. Prog. 47
(4), 130–133.
Perry, D.J., Noakes, T.J., Helliwell, P.S., 2007. Guidelines for the
management of patients on oral anticoagulants requiring dental
surgery. Br. Dent. J. 203 (7), 389–393.
Revenco, D., Morgan, J.P., Tsao, L., 2011. The dilemma of
implantable cardioverter-deﬁbrillator therapy in the geriatric pop-
ulation. J. Geriatr. Cardiol. 8 (3), 195–200.
Richards, D., 2008. Guidelines for the management of patients who
are taking oral anticoagulants and who require dental surgery.
Evid. Based Dent. 9 (1), 5–6.
Roedig, J.J., Shah, J., Elayi, C.S., Miller, C.S., 2010. Interference of
cardiac pacemaker and implantable cardioverter-deﬁbrillatoractivity during electronic dental device use. J. Am. Dent. Assoc.
141 (5), 521–526.
Steinhauer, T., Bsoul, S.A., Terezhalmy, G.T., 2005. Risk stratiﬁcation
and dental management of the patient with cardiovascular diseases.
Part I: etiology, epidemiology, and principles of medical manage-
ment. Quintessence Int. 36 (2), 119–137.
Stokes, T., Richey, R., Wray, D., 2008. Prophylaxis against infective
endocarditis: summary of NICE guidance. Heart 94 (7), 930–931.
Suazo Galdames, I.C., Cantin Lopez, M.G., Zavando Matamala,
D.A., 2008. Inferior alveolar nerve block anesthesia via the
retromolar triangle, an alternative for patients with blood
dyscrasias. Med. Oral Patol. Oral Cir. Bucal. 13 (1), E43–E47.
Theodotou, N., Cillo Jr., J.E., 2009. Brugada syndrome (sudden
unexpected death syndrome): perioperative and anesthetic man-
agement in oral and maxillofacial surgery. J. Oral Maxillofac. Surg.
67 (9), 2021–2025.
Tompkins, C., Cheng, A., Dalal, D., Brinker, J.A., Leng, C.T.,
Marine, J.E., et al, 2010. Dual antiplatelet therapy and heparin
‘‘bridging’’ signiﬁcantly increase the risk of bleeding complications
after pacemaker or implantable cardioverter-deﬁbrillator device
implantation. J. Am. Coll. Cardiol. 55 (21), 2376–2382.
Washizuka, T., Chinushi, M., Kazama, R., Hirono, T., Watanabe, H.,
Komura, S., et al, 2005. Inappropriate discharges of intravenous
implantable cardioverter deﬁbrillators owing to lead failure. Int.
Heart J. 46 (5), 909–913.
Wraith, A., 1999. Pain and anxiety control in dentistry. SAAD Dig. 16
(3), 2.
Zareba, W., Moss, A.J., Daubert, J.P., Hall, W.J., Robinson, J.L.,
Andrews, M., 2003. Implantable cardioverter deﬁbrillator in high-
risk long QT syndrome patients. J. Cardiovasc. Electrophysiol. 14
(4), 337–341.
